SEC Form 4 · accession 0001123292-16-002364
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stewart McCallum
Officer — Chief Medical Officer
Period of report
May 26, 2016
Accepted (ET)
May 31, 2016 · 3:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 26, 2016 | P | 1,000 | $8.15 | A | 1,000 | D | |
| Common Stock | May 31, 2016 | P | 250 | $8.50 | A | 1,250 | D |
Table II — derivative securities
No Table II lines on this filing.